RecallRadar

FDA Drug recall D-0867-2023

Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc., Manufactured by: GSMS Incorpor…

On 2023-06-14 the FDA classified a Class II recall of Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc., Manufactured by: GSMS Incorpor… by Golden State Medical Supply, citing lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0867-2023
ClassificationClass II
Statusterminated
Initiated2023-05-25
Published2023-06-14
Last updated2026-09-13 11:52 UTC
CompanyGolden State Medical Supply
DistributionUS

Product

Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc., Manufactured by: GSMS Incorporated, Camarillo, CA 93012, a) NDC 51407-731-25 (2.5 mL bottle), b) NDC 51407-731-05 (5 mL bottle).

Reason

Lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container.

Identifiers

ndc51407-731-25
ndc51407-731-05
code_infoLot #s: a) GS049666, GS049807, Exp: 03/31/2024; b) GS049667, GS051447, Exp: 09/30/2024.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0867-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.